Published in Cancer Treat Rev on March 01, 1980
Extravasation injuries in adults. ISRN Dermatol (2013) 0.90
A review of clinical experience with paclitaxel extravasations. Support Care Cancer (2003) 0.82
Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol. Support Care Cancer (2014) 0.81
Management of the extravasation of anti-neoplastic agents. Support Care Cancer (2015) 0.80
Experimental chemotherapy-induced skin necrosis in swine. Mechanistic studies of anthracycline antibiotic toxicity and protection with a radical dimer compound. J Clin Invest (1988) 0.78
Cancer chemotherapy agent-induced perivenous extravasation injuries. Postgrad Med J (1987) 0.76
Resistance to the cytocidal effects of adriamycin is an early phenotypic change induced during hepatocarcinogenesis. Br J Cancer (1981) 0.76
Increasing the benefits of chemotherapy by ameliorating the adverse effects. Can Fam Physician (1987) 0.75
Extravasation emergencies: state-of-the-art management and progress in clinical research. Memo (2016) 0.75
Practical cancer chemotherapy: venous access and extravasation. Can Fam Physician (1985) 0.75
Endoscopic local injection of a new drug delivery formulation, anticancer drug bound to carbon particles, for digestive cancers: pilot study. J Gastroenterol (1997) 0.75
[Extravasation of cytotoxic agents]. Wien Klin Wochenschr (2004) 0.75
Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst (1996) 2.12
Representation of older patients in cancer treatment trials. Cancer (1994) 2.06
The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. N Engl J Med (1995) 1.74
Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol (1986) 1.70
Retinoids in cancer therapy. J Clin Oncol (1992) 1.59
Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103. J Clin Oncol (1993) 1.44
Comorbid psychopathology in binge eating disorder: relation to eating disorder severity at baseline and following treatment. J Consult Clin Psychol (2000) 1.40
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol (1989) 1.28
Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev (1988) 1.25
The therapy of osteogenic sarcoma: current status and thoughts for the future. J Surg Oncol (1972) 1.24
Thalamo-cortical processing of vibrissal information in the rat. I. Intracortical origins of surround but not centre-receptive fields of layer IV neurones in the rat S1 barrel field cortex. J Comp Neurol (1991) 1.21
Primary hepatocellular cancer--present results and future prospects. Int J Radiat Oncol Biol Phys (1983) 1.20
Antineoplastic activity of cannabinoids. J Natl Cancer Inst (1975) 1.14
1991 national survey of carcinoma of the breast by the Commission on Cancer. J Am Coll Surg (1994) 1.09
Accrual to clinical trials. J Natl Cancer Inst (1988) 1.09
National Cancer Institute's evaluation of unconventional cancer treatments. J Natl Cancer Inst (1992) 1.08
Neonatal parathyroid function: role of gestational age and postnatal age. J Pediatr (1973) 1.06
Tamoxifen: trials, tribulations, and trade-offs. J Natl Cancer Inst (1994) 1.05
Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer (1986) 1.03
A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes. J Clin Oncol (1986) 1.02
Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals. JAMA (1978) 0.98
5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma. Eur J Cancer (1972) 0.97
Insurance coverage of patients with breast cancer in the 1991 commission on cancer patient care evaluation study. Ann Surg Oncol (1994) 0.96
Evolution of time coding systems. Neural Comput (1999) 0.96
Inhibition by aflatonin B-1 of hydrocortisone induction of rat liver tryptophan pyrrolase and tyrosine transaminase. Arch Biochem Biophys (1968) 0.95
Metabolism, disposition and excretion of [14C]melamine in male Fischer 344 rats. Food Chem Toxicol (1983) 0.95
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. J Clin Oncol (1991) 0.95
Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Ann Intern Med (1984) 0.93
A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma. J Clin Oncol (1985) 0.92
Metabolism of benzophenone-3 in rats. Drug Metab Dispos (1993) 0.91
Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial. J Clin Oncol (1995) 0.91
Rapid gastric absorption of sodium nitrite in mice. J Pharm Sci (1972) 0.91
Pharmacokinetics of benzophenone-3 after oral exposure in male rats. J Appl Toxicol (1995) 0.90
Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol (1987) 0.89
Relationship between acrylamide reproductive and neurotoxicity in male rats. Reprod Toxicol (2000) 0.89
Disposition of benzophenone-3 after dermal administration in male rats. Toxicol Lett (1994) 0.89
1-Aminobenzotriazole inhibits acrylamide-induced dominant lethal effects in spermatids of male mice. Mutagenesis (2000) 0.88
Estrogen receptors in male breast cancer: clinical and pathologic correlations. Cancer (1981) 0.88
Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study. Cancer Treat Rep (1980) 0.88
A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958). Cancer Treat Rev (1980) 0.87
Pharmacokinetics and metabolism of ftorafur in man. Cancer Treat Rep (1979) 0.86
Testicular cancer: role of biological tumor markers. Cancer Treat Rev (1979) 0.86
Hepatomas: hormone receptors and therapy. Am J Med (1982) 0.86
Patient accrual to clinical trials. Cancer Treat Rep (1987) 0.86
Adjuvant therapy for breast cancer patients with negative lymph nodes. NCI Monogr (1986) 0.85
Additive and synergistic inhibition of mammalian microsomal enzyme functions by piperonyl butoxide, safrole and other methylenedioxyphenyl derivatives. Experientia (1971) 0.85
Time coding in the midbrain of mormyrid electric fish. I. Physiology and anatomy of cells in the nucleus exterolateralis pars anterior. J Comp Physiol A (1998) 0.85
Clinical development of Taxol. J Natl Cancer Inst Monogr (1993) 0.84
Neoadjuvant therapy in cancer treatment. Cancer (1993) 0.84
Adjuvant multimodality treatment of rectal cancer. Br J Surg (1989) 0.83
Malignant pleural effusions. Cancer Treat Rev (1978) 0.83
Some structural and functional consequences of hepatic adenosine triphosphate deficiency induced by intraperitoneal D-fructose administration. Lab Invest (1970) 0.82
Meeting highlights: a reappraisal of research results for the local treatment of early stage breast cancer. J Natl Cancer Inst (1995) 0.82
Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma. J Clin Oncol (1986) 0.82
Surgical oncology research. A disappointing status report. Ann Surg (1988) 0.82
Induction of tunica vaginalis mesotheliomas in rats by xenobiotics. Crit Rev Toxicol (2009) 0.81
Liver nuclear RNA metabolism in rats treated with aflatoxin B1. Life Sci II (1970) 0.81
Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study. Cancer Treat Rep (1979) 0.81
Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexate. Cancer Chemother Pharmacol (1982) 0.80
Preventing chemotherapy errors. Am J Health Syst Pharm (1996) 0.80
Differentiating agents in the treatment of human malignancies. Cancer Treat Rev (1986) 0.80
The clinical value of hormone receptor assays in malignant disease. Cancer Treat Rev (1978) 0.80
Paclitaxel (Taxol) in breast cancer. Hematol Oncol Clin North Am (1994) 0.80
Therapy of hepatocellular cancer with combined intrahepatic arterial chemotherapy and whole liver irradiation. Ann Acad Med Singapore (1980) 0.80
Neurotoxicity of glycidamide, an acrylamide metabolite, following intraperitoneal injections in rats. J Toxicol Environ Health (1993) 0.79
Direct effect of the neurotoxicant acrylamide on kinesin-based microtubule motility. J Neurosci Res (1996) 0.79
Angiogenesis inhibitors. A promising role in cancer therapy. Cancer Pract (1999) 0.79
Manufacturer's warning regarding unapproved uses of misoprostol. N Engl J Med (2001) 0.79
Some thoughts on the future of clinical trials in cancer. Cancer Treat Rep (1986) 0.79
New chemotherapeutic agents in non-small-cell lung cancer. Semin Oncol (1993) 0.79
Adjusting heparin infusion rates from the initial response to activated coagulation time. Drug Intell Clin Pharm (1983) 0.79
Hormone receptors in renal cell carcinoma. Their utility as predictors of response to endocrine therapy. Cancer Chemother Pharmacol (1981) 0.79
Rat two-generation reproduction and dominant lethal study of acrylamide in drinking water. Reprod Toxicol (2000) 0.78
Parathyroid function in infants of diabetic mothers. J Pediatr (1975) 0.78
How accurate are computed tomographic scans in assessment of changes in tumor size? Am J Med (1983) 0.78
Chemotherapy of disseminated gastric cancer. A joint effort of the Northern California Oncology Group and the Japanese Gastric Cancer Chemotherapy Group. Cancer (1983) 0.78
Toxic neurofilamentous axonopathies and fast axonal transport. V. Reduced bidirectional vesicle transport in cultured neurons by acrylamide and glycidamide. J Toxicol Environ Health (1994) 0.78
Combined radiotherapy and multidrug chemotherapy for advanced head and neck cancer: results of a Radiation Therapy Oncology Group pilot study. Cancer Treat Rep (1979) 0.78
Progress against rare and not-so-rare cancers. N Engl J Med (1992) 0.78
Sequential combination of bleomycin and mitomycin in advanced cervical cancer--an American experience: a Northern California Oncology Group study. Cancer Treat Rep (1982) 0.78
The distribution of [14C]caprolactam in male, female and pregnant mice. Food Chem Toxicol (1984) 0.77
Role of dimethylnitrosamine-demethylase in the metabolic activation of dimethylinitrosamine. Chem Biol Interact (1979) 0.77
The distribution of [14C]acrylamide in male and pregnant Swiss-Webster mice studied by whole-body autoradiography. Toxicol Appl Pharmacol (1986) 0.77
Carcinogen activation by human liver enzymes in the Ames mutagenicity test. Mutat Res (1977) 0.77
The fluoropyrimidines: biochemical mechanisms and design of clinical trials. Cancer Chemother Pharmacol (1978) 0.77
Suppression of dimethylnitrosamine metabolism and toxicity by nitrososarcosine and other nitrosamines. Toxicol Appl Pharmacol (1976) 0.77
Trans-retinoic acid and related differentiation agents. Semin Oncol (1992) 0.77
Response of the pituitary and thyroid to tropic hormones in Sprague-Dawley versus Fischer 344 male rats. Toxicol Sci (1999) 0.77
Retinoids in the lateral eye of Limulus: evidence for a retinal photoisomerase. Vis Neurosci (1992) 0.77
Hepatic intraarterial chemotherapy--current status and future prospects--"If you have a short sword, take a step forward". Gan To Kagaku Ryoho (1983) 0.76
Hormone receptors in hepatoblastoma: a demonstration of both estrogen and progesterone receptors. Cancer (1982) 0.76
Determination of liver, kidney, and spleen volumes by computed tomography: an experimental study in dogs. J Comput Assist Tomogr (1981) 0.76
Protective effects of freeze dried swordfish on methylmercury chloride toxicity in rats. Bull Environ Contam Toxicol (1978) 0.76
Arsenic trioxide for the treatment of acute promyelocytic leukemia. Cancer Pract (2002) 0.76
Pathologic analysis of mink mortality in New England mink. Arch Environ Contam Toxicol (1977) 0.76
Changes in thyroid gland morphology after acute acrylamide exposure. Toxicol Sci (1999) 0.76